CUSIP 207523101ADSQ4 2025
28 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Eversource Wealth Advisors, LLC | 1.3K | $3.6K |
| 4 | Nov 28, 2025 | Wei Zheng | 13G/A | 9.9% | 5.53M | SEC |
| 5 | Jul 21, 2025 | Panacea Innovation Limited | 13D/A | 25.1% | — | SEC |
| 6 | Jul 1, 2024 | Panacea Innovation Ltd | 13D/A | 24.3% | 13.41M | SEC |
| 7 | Feb 27, 2024 | Panacea Innovation Ltd | 13D/A | 21.8% | 12.00M | SEC |
| 8 | Feb 27, 2024 | Ra Capital Management, L.P. | 13D/A | — | — | SEC |
| 9 | Feb 13, 2024 | Wei Zheng | 13G/A | 11.7% | 6.49M | SEC |
| 10 | Feb 13, 2024 | Biofortune Inc | 13G/A | 11.2% | 6.16M | SEC |
See the full Schedule 13D/13G history for Connect Biopharma Hldgs Ltd.
Unlock full history